
About Uniqlife Biosciences Private Limited
Data last updated:
Uniqlife Biosciences Private Limited is a private limited company based in Agra, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 May 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51101UP2012PTC050651. Its GSTIN is 09AABCU4540K1Z5 (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors Neeraj Sharma and Pinkey Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Satyam Multiplex Office No. 7 First Floor 103 Sector 12A Avas Vikas Colony, Agra, Uttar Pradesh, India – 282007.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.34 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹27.8 Lakh (net margin 3%) and EBITDA of ₹98.7 Lakh (EBITDA margin 10.6%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 12% over five years.
The company has about 33 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Uniqlife BioSciences. As per MCA filings, the company has open charges of ₹4.14 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website uniqlife.in.
Company details
Contact details
Uniqlife Biosciences Private Limited's registered office is in Agra, Uttar Pradesh. Its website is uniqlife.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSatyam Multiplex Office No. 7 First Floor 103 Sector 12A Avas Vikas Colony, Agra, Uttar Pradesh, India – 282007
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Uniqlife Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Uniqlife Biosciences operates one associated brand: Uniqlife BioSciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and supplying pharmaceutical medicines and injections under WHO standards in India. | uniqlife.in |
Business activity
The main business activity of Uniqlife Biosciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Uniqlife Biosciences Private Limited, buy the company report.
Financials of Uniqlife Biosciences Private Limited
FY 2025 filings availableUniqlife Biosciences Private Limited reported revenue of ₹9.34 Cr (up 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 18% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹98.7 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹27.8 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.6% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Uniqlife Biosciences Private Limited, buy the company report.
Board of directors of Uniqlife Biosciences Private Limited
Uniqlife Biosciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neeraj Sharma | Director | 01 Feb 2014 | 12 Years 9 Months | Current |
| Pinkey Sharma | Director | 24 May 2012 | 14 Years 5 Months | Current |
Peer comparison
Uniqlife Biosciences Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Biosciences, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Osbro Pharmaceutical Private Limited | ₹9.34 Cr (FY 2022) | -11.0% | Pune, Maharashtra, India | |||
| Uniqlife Biosciences Private Limitedthis company | ₹9.34 Cr (FY 2025) | ₹27.8 Lakh | 3% | 18.0% | 33 | Agra, Uttar Pradesh, India |
| Idealife Healthcare Limited | ₹9.32 Cr (FY 2025) | 11.0% | Kanpur, Uttar Pradesh, India | |||
| Palmo Industrial Silicones Private Limited | ₹9.32 Cr (FY 2025) | 7.0% | Vadodara, Gujarat, India | |||
| Poddar Pharmaceuticals Private Limited | ₹9.25 Cr (FY 2024) | 83.0% | Uttar Pradesh, India | |||
| Thio Chemi Private Limited | ₹9.24 Cr (FY 2025) | 55.0% | Coimbatore, Tamil Nadu, India |
To see the full peer comparison of Uniqlife Biosciences Private Limited, buy the company report.
Auditor
Uniqlife Biosciences Private Limited is audited by A.C.H.G & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A.C.H.G & ASSOCIATES | FY 2023 | 012705C |
Shareholding
The shareholding of Uniqlife Biosciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Uniqlife Biosciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Mar 2024 | 100907928 | Indian Overseas Bank | ₹15 Lakh | Open | |
| 30 Sep 2023 | 100816245 | Indian Overseas Bank | ₹13.5 Lakh | Open | |
| 18 Oct 2022 | 100627879 | Indian Overseas Bank | ₹10 Lakh | Open | |
| 31 Aug 2022 | 100627885 | Indian Overseas Bank | ₹33 Lakh | Open | |
| 15 Jul 2020 | 100357504 | Indian Overseas Bank | ₹27 Lakh | Open |
To see the full charge records of Uniqlife Biosciences Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
No court or tribunal cases involving Uniqlife Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Uniqlife Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Uniqlife Biosciences Private Limited has a workforce of 33 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 33 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Uniqlife Biosciences Private Limited, buy the company report.
GST
Uniqlife Biosciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCU4540K1Z5 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Uniqlife Biosciences Private Limited, buy the company report.
Recent activity
Uniqlife Biosciences Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Rajendra Kumar Sharma ceased to be Director on 17 Mar 2017.
3 earlier events are in the company report.
Frequently asked questions
Uniqlife Biosciences is an active private limited company based in Agra, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 May 2012 (14+ years old) and is registered under CIN U51101UP2012PTC050651.
Uniqlife Biosciences has 2 current directors:
- Neeraj Sharma - Director
- Pinkey Sharma - Director
The latest financial statements of Uniqlife Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Uniqlife Biosciences is 09AABCU4540K1Z5, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Uniqlife Biosciences is U51101UP2012PTC050651. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Uniqlife Biosciences was incorporated on 24 May 2012, making it 14+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Uniqlife Biosciences by revenue are Osbro Pharmaceutical Private Limited, Idealife Healthcare Limited, Palmo Industrial Silicones Private Limited, Poddar Pharmaceuticals Private Limited, Thio Chemi Private Limited, all in the Pharma industry (Biosciences, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rajendra Kumar Sharma ceased to be Director on 17 Mar 2017. Neeraj Sharma was appointed as Director on 01 Feb 2014. Neeraj Sharma ceased to be Director on 05 Aug 2013. Uniqlife Biosciences has 4 board changes on record in total.
Uniqlife Biosciences can be reached through the website uniqlife.in. Its registered office is in Agra, Uttar Pradesh, India.
The registered office of Uniqlife Biosciences is at Satyam Multiplex Office No. 7 First Floor 103 Sector 12A Avas Vikas Colony, Agra, Uttar Pradesh, India – 282007.
Uniqlife Biosciences operates in the pharma industry, in the drug formulation and development segment.

